BioCentury
ARTICLE | Clinical News

DMI begins Ciprofloxacin GR study

October 1, 2001 7:00 AM UTC

DepoMed (DMI) began a Phase II study comparing its Ciprofloxacin GR extended-release formulation to the marketed immediate-release formulation, Cipro ciprofloxacin from Bayer (FSE:BAYG). The double-bl...